These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2994662

  • 1. Purification of the epidermal growth factor receptor by tyrosine-Sepharose affinity chromatography.
    Akiyama T, Kadooka T, Ogawara H.
    Biochem Biophys Res Commun; 1985 Aug 30; 131(1):442-8. PubMed ID: 2994662
    [Abstract] [Full Text] [Related]

  • 2. Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation.
    Weber W, Bertics PJ, Gill GN.
    J Biol Chem; 1984 Dec 10; 259(23):14631-6. PubMed ID: 6094567
    [Abstract] [Full Text] [Related]

  • 3. Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity.
    Downward J, Waterfield MD, Parker PJ.
    J Biol Chem; 1985 Nov 25; 260(27):14538-46. PubMed ID: 2997213
    [Abstract] [Full Text] [Related]

  • 4. Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors.
    McGlynn E, Becker M, Mett H, Reutener S, Cozens R, Lydon NB.
    Eur J Biochem; 1992 Jul 01; 207(1):265-75. PubMed ID: 1321046
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Amiloride directly inhibits growth factor receptor tyrosine kinase activity.
    Davis RJ, Czech MP.
    J Biol Chem; 1985 Feb 25; 260(4):2543-51. PubMed ID: 2982824
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, possessing high numbers of EGF receptors.
    Gamou S, Kim YS, Shimizu N.
    Mol Cell Endocrinol; 1984 Sep 25; 37(2):205-13. PubMed ID: 6092175
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity.
    Cochet C, Gill GN, Meisenhelder J, Cooper JA, Hunter T.
    J Biol Chem; 1984 Feb 25; 259(4):2553-8. PubMed ID: 6321473
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Purification of denatured epidermal growth factor-receptor from A431 human epidermoid carcinoma cells.
    Decker S.
    Arch Biochem Biophys; 1984 Feb 01; 228(2):621-6. PubMed ID: 6320745
    [Abstract] [Full Text] [Related]

  • 16. Tumor-promoting phorbol diesters mediate phosphorylation of the epidermal growth factor receptor.
    Davis RJ, Czech MP.
    J Biol Chem; 1984 Jul 10; 259(13):8545-9. PubMed ID: 6330113
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor.
    Parker PJ, Young S, Gullick WJ, Mayes EL, Bennett P, Waterfield MD.
    J Biol Chem; 1984 Aug 10; 259(15):9906-12. PubMed ID: 6086658
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.